Steroid-refractory acute graft versus host disease
Clinical trials for Steroid-refractory acute graft versus host disease explained in plain language.
Never miss a new study
Get alerted when new Steroid-refractory acute graft versus host disease trials appear
Sign up with your email to follow new studies for Steroid-refractory acute graft versus host disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood cells aim to tame deadly transplant complication
Disease control Not yet recruitingThis early-phase trial tests a new treatment called CK0802 for people with severe graft-versus-host disease (GVHD) that does not respond to steroids. GVHD is a serious complication after a bone marrow or stem cell transplant, where donor immune cells attack the patient's body. CK…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
Phase 1/2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Stem cell combo shows promise for deadly transplant complication
Disease control Not yet recruitingThis Phase 3 trial tests whether adding a stem cell therapy called remestemcel-L to the drug ruxolitinib can help adults with severe, steroid-resistant graft-versus-host disease (GVHD) after a bone marrow transplant. GVHD occurs when donor immune cells attack the patient's body. …
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
Phase 3 • Sponsor: Mesoblast, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC